Lucid Diagnostics (LUCD) Gross Profit (2021 - 2026)

Lucid Diagnostics (LUCD) posted Gross Profit of -$325000.0 for Q1 2026, up 10.22% on a QoQ basis from -$362000.0 in Q4 2025, and up 55.05% year-over-year from -$209612.0 in Q1 2025.

Lucid Diagnostics (LUCD) Gross Profit (2021 - 2026) Analysis & Trends

Lucid Diagnostics' Gross Profit history runs 6 years deep, the most recent figure standing at -$325000.0 for Q1 2026.

  • Quarterly Gross Profit rose 55.05% year-over-year to -$325000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 million (up 45.55% YoY) and the FY2025 annual result came in at -$2.0 million, up 28.44% from the prior year.
  • Gross Profit was -$325000.0 for Q1 2026 at Lucid Diagnostics, up from -$362000.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $112000.0 in Q4 2022 and bottomed at -$1.4 million in Q2 2023.
  • A 5-year average of -$534625.0 and a median of -$499000.0 in 2024 frame the typical range for Gross Profit.
  • Annual changes were most pronounced in 2023 — Gross Profit sank 1219.74% — and 2025, when it jumped 61.81%.
  • Lucid Diagnostics' Gross Profit stood at $112000.0 in 2022, then sank by 472.32% to -$417000.0 in 2023, then tumbled by 127.34% to -$948000.0 in 2024, then soared by 61.81% to -$362000.0 in 2025, then climbed by 10.22% to -$325000.0 in 2026.
  • Business Quant data shows LUCD's Gross Profit at -$325000.0 in Q1 2026, -$362000.0 in Q4 2025, and -$486000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Lucid Diagnostics 133.09 Mn 105.22 Mn -325,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -325,000.00
Mar 31, 2026 -325,000.00
Dec 31, 2025 -362,000.00
Dec 31, 2025 -362,000.00
Sep 30, 2025 -486,000.00
Sep 30, 2025 -486,000.00
Jun 30, 2025 -363,000.00
Jun 30, 2025 -363,000.00
Mar 31, 2025 -723,000.00
Mar 31, 2025 -723,000.00
Dec 31, 2024 -948,000.00
Dec 31, 2024 -948,000.00
Sep 30, 2024 -512,000.00
Sep 30, 2024 -512,000.00
Jun 30, 2024 -638,000.00
Jun 30, 2024 -638,000.00
Mar 31, 2024 -655,000.00
Mar 31, 2024 -655,000.00
Dec 31, 2023 -417,000.00
Dec 31, 2023 -417,000.00